Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03851614
Title Basket Combination Study of Inhibitors of DNA Damage Response, Angiogenesis and Programmed Death Ligand 1 in Patients With Advanced Solid Tumors (DAPPER)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors University Health Network, Toronto
Indications

colorectal cancer

pancreatic adenocarcinoma

leiomyosarcoma

Therapies

Cediranib + Durvalumab

Durvalumab + Olaparib

Age Groups: adult | senior
Covered Countries CAN

Additional content available in CKB BOOST